Rhodiola

Key Research Papers and Clinical Trials

Current research on Rhodiola spans multiple therapeutic areas, from basic mechanisms to clinical applications, though many studies are still in early phases.

Laboratory and Preclinical Research

Recent laboratory studies have explored Rhodiola's active compounds and mechanisms. One 2026 study investigated salidroside (a key Rhodiola compound) for endothelial inflammation, examining how it affects NF-κB and NLRP3 inflammasome signaling pathways. Another preclinical study looked at Rhodiola rosea extract's protective effects against drug-induced liver and kidney toxicity, focusing on Nrf2/HO-1 activation and inflammatory pathway inhibition.

Research has also examined Rhodiola for skin conditions, with a 2026 study using zebrafish and mouse models to investigate Rhodiola crenulata for atopic dermatitis through computational analysis. Additionally, researchers have studied phenylpropanoids from Rhodiola fastigiata for antimalarial properties.

Some studies have focused on novel delivery methods, including research on salidroside-based nanomedicines for triple-negative breast cancer, though this appears to be primarily mechanistic rather than clinical research.

Clinical Trial Activity

Several clinical trials have been conducted or are ongoing, though specific sample sizes and detailed results are not provided in the available evidence:

• A completed Phase 4 trial examined Rhodiola rosea in adults with ADHD (NCT02737020)
• Studies on stress management using Rhodiola-containing supplements have been completed (NCT05830565, NCT06889584)
• A Phase 2/3 trial investigated Rhodiola for coronary microvascular disease (NCT04218916), though the current status is unknown
• Research on short-term Rhodiola use in basketball players examined effects on game time, fatigue, and performance (NCT07239960)

Research Limitations

The available evidence shows primarily preclinical research with limited detailed clinical trial results. Many studies focus on isolated compounds from Rhodiola rather than whole-plant extracts, and sample sizes for clinical trials are not specified in the current evidence. More robust clinical data would be needed to fully evaluate Rhodiola's therapeutic potential across these various applications.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using Rhodiola or any supplement for medical conditions.